Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 30, 2017

DrugPatentWatch Database Preview

CEVIMELINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

What is the patent landscape for Cevimeline Hydrochloride, and when can generic versions of Cevimeline Hydrochloride launch?

Cevimeline Hydrochloride is a drug marketed by Novel Labs Inc, Apotex Inc, Pack Pharms Llc, and West-ward Pharms Int. and is included in four NDAs.

The generic ingredient in CEVIMELINE HYDROCHLORIDE is cevimeline hydrochloride. There are four drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the cevimeline hydrochloride profile page.

Summary for Tradename: CEVIMELINE HYDROCHLORIDE

Patents:0
Applicants:4
NDAs:4
Suppliers / Packagers: see list5
Bulk Api Vendors: see list35
Clinical Trials: see list986
Patent Applications: see list560
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CEVIMELINE HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: CEVIMELINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novel Labs Inc
CEVIMELINE HYDROCHLORIDE
cevimeline hydrochloride
CAPSULE;ORAL204746-001Dec 30, 2016ABRXNoNo► Subscribe► Subscribe
West-ward Pharms Int
CEVIMELINE HYDROCHLORIDE
cevimeline hydrochloride
CAPSULE;ORAL091591-001Jul 8, 2013ABRXNoNo► Subscribe► Subscribe
Apotex Inc
CEVIMELINE HYDROCHLORIDE
cevimeline hydrochloride
CAPSULE;ORAL091260-001Aug 25, 2011ABRXNoNo► Subscribe► Subscribe
Pack Pharms Llc
CEVIMELINE HYDROCHLORIDE
cevimeline hydrochloride
CAPSULE;ORAL203775-001Jun 4, 2014ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Find generic sources and suppliers
  • Identify first generic entrants

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot